Vita 34 AG 16.02.2015 14:55 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of voting rights pursuant to Art. 25, Sec. 1 WpHG We received the following notification pursuant to Art. 25, Sec. 1 WpHG on February 11, 2015: 1. Listed company: Vita 34 AG Deutscher Platz 5a, 04103 Leipzig, Germany 2. Notifier: Human Stem Cells Institute OJSC, Moscow, Russian Federation 3. Triggering event: Exceeding Threshold 4. Threshold(s) crossed or reached: 5% and 10% 5. Date at which the threshold is crossed or reached: 24.12.2014 6. Total amount of voting rights: 11.21% (equals 339462 voting rights) calculated from the following total number of voting rights issued: 3026500 7. Detailed information on the voting rights proportion: Voting rights proportion based on financial/other instruments pursuant to Art. 25 WpHG: 2.64% (equals 80000 voting rights) thereof held indirectly: 0% (equals 0 voting rights) Voting rights pursuant to Art. 21, 22 WpHG: 8.57% (equals 259462 voting rights) 8. Detailed information on financial/other instruments pursuant to Art. 25 WpHG: Exercise period: Any time 16.02.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Vita 34 AG Deutscher Platz 5a 04103 Leipzig Germany Internet: www.vita34.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-PVR: Vita 34 AG: Publication according to § 26 paragraph. 1 WpHG with the objective of Europe-wide distribution
| Source: EQS Group AG